Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Edrophonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 6/20 | 1.00 |
| ▸ | TSHR | P16473 | 4/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 0.96 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.96 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edrophonium SCHEMBL29627074 | 1.00 | ACHE (1.00) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL8009388 | 1.00 | ACHE (1.00) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL34789 | 0.98 | ACHE (1.00) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL10893553 | 0.98 | ACHE (0.96) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL19148596 | 0.98 | ACHE (1.00) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL2462104 | 0.98 | ACHE (1.00) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL10893551 | 0.96 | ACHE (0.96) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL4065806 | 0.89 | ACHE (0.83) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| SCHEMBL4611923 | 0.83 | ACHE (0.71) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| SCHEMBL4611780 | 0.81 | ACHE (0.68) | ACHETSHROPRM1BLMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 18124 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4029690-B1 | METAL-CLAD LAMINATE FOR FLEXIBLE ELECTRONIC DEVICES, AND FLEXIBLE ELECTRONIC DEVICE USING SAME | NIPPON STEEL CHEMICAL & MAT CO LTD (JP) | 2026-04-22 | — | — | EP | claimed |
| US-20260097063-A1 | ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES | REGENERON PHARMA (US) | 2026-04-09 | — | — | US | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-12570785-B2 | Thermoplastic polyurethane resin elastomers | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-03-10 | — | — | US | claimed |
| EP-4665351-A1 | IMPROVING GLYMPHATIC-LYMPHATIC EFFLUX | University of Rochester (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4635489-A1 | COMPOSITION FOR PREVENTING OR TREATING SIDE EFFECTS OF CHOLINESTERASE INHIBITORS | Dr.Noah Biotech Inc. (KR) | 2025-10-22 | — | — | EP | claimed |
| US-20250271426-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | FIRMENICH INCORPORATED (US) | 2025-08-28 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| EP-4249494-B1 | A DRUG COMPRISING A RADICAL GENERATING CATALYST | ACENET INC (JP) | 2025-07-16 | — | — | EP | claimed |
| US-5010056-A | Growth disorders | PIERREL SPA (IT) | 1991-04-23 | — | — | US | claimed |
| EP-0166724-B1 | COMPOSITION FOR TREATING PEDICULOSIS | SOFT SHEEN PRODUCTS, INC. (US) | 1990-11-22 | — | — | EP | claimed |
| US-4952586-A | FOR ANTAGONIZING NONDEPOLARIZING NEUROMUSCULAR BLOCKADE WHEN MUSCLE RELAXATION IS NOT NEEDED | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1990-08-28 | — | — | US | claimed |
| EP-0301392-A1 | Pharmaceutical composition for intranasal administration comprising GH - Releasing hormone, a cholinergic agonist and in case a bile salt | Pierrel S.p.A. (IT) | 1989-02-01 | — | — | EP | claimed |
| US-4661509-A | ENZYME INHIBITORS | GORDON ARNOLD Z | 1987-04-28 | — | — | US | claimed |
| US-4590166-A | WASHING WITH WATER AND ALCOHOL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1986-05-20 | — | — | US | claimed |
| EP-0166724-A1 | COMPOSITION FOR TREATING PEDICULOSIS. | SOFT SHEEN PRODUCTS INC (US) | 1986-01-08 | — | — | EP | claimed |
| US-4562196-A | ANTAGONIST OF MUSCLE RELAXANTS | NELSON RESEARCH & DEVELOPMENT (US) | 1985-12-31 | — | — | US | claimed |
| WO-1985002755-A1 | METHOD AND COMPOSITION FOR TREATING PEDICULOSIS | SOFT SHEEN PRODUCTS, INC. (US) | 1985-07-04 | — | — | WO | claimed |
| US-4439427-A | Method and composition for treating pediculosis | SOFT SHEEN PRODUCTS, INC. (US) | 1984-03-27 | — | — | US | claimed |